Tissue engineered regeneration of completely transected spinal cord using human mesenchymal stem cells

Biomaterials

Volumn 33, Issue 19, 2012, Pages 4828-4835

  Kang, Kkot Nim ^a   Kim, Da Yeon ^a   Yoon, So Mi ^a   Lee, Ju Young ^a   Lee, Bit Na ^a   Kwon, Jin Seon ^a   Seo, Hyo Won ^a   Lee, Il Woo ^b   Shin, Ha Cheol ^c   Kim, Young Man ^c   Kim, Hyun Soo ^c   Kim, Jae Ho ^a   Min, Byoung Hyun ^a   Lee, Hai Bang ^a   Kim, Moon Suk ^a  

^a Ajou University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c FCB Pharmicell Company   (South Korea)

Author keywords

Human mesenchymal stem cells; Nerve; Regeneration; Scaffold; Spinal cord injury

Indexed keywords

AXONAL REGENERATION; CELL SURVIVAL; CONTROL GROUPS; FUNCTIONAL RECOVERY; HIND LIMBS; HUMAN MESENCHYMAL STEM CELLS; HUMAN MESENCHYMAL STEM CELLS (HMSCS); IMMUNOHISTOCHEMICAL STAINING; IN-CONTROL; IN-VIVO; NERVE; NERVE REGENERATION; PLGA SCAFFOLDS; POLY(D ,L-LACTIDE-CO-GLYCOLIDE); REGENERATION; SELF-RECOVERY; SPINAL CORD INJURIES (SCI); SPINAL CORDS; THREE-DIMENSIONAL SCAFFOLDS;

ANIMALS; BIPED LOCOMOTION; ELECTROPHYSIOLOGY; NEURONS; PATIENT REHABILITATION; RATS; SCAFFOLDS; STEM CELLS; TISSUE;

SCAFFOLDS (BIOLOGY);

POLYGLACTIN; TISSUE SCAFFOLD;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CONVALESCENCE; EVOKED MUSCLE RESPONSE; FEMALE; HINDLIMB; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIMB MOVEMENT; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE CELL DIFFERENTIATION; NERVE FIBER REGENERATION; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; RAT; SPINAL CORD NERVE CELL; SPINAL CORD REGENERATION; SPINAL CORD TRANSSECTION; TISSUE ENGINEERING;

ANIMALS; CELLS, CULTURED; ELECTROPHYSIOLOGY; FEMALE; HUMANS; LACTIC ACID; MESENCHYMAL STEM CELLS; POLYGLYCOLIC ACID; RATS, INBRED F344; SPINAL CORD INJURIES; TISSUE SCAFFOLDS;

ANIMALIA; RATTUS;

EID: 84859860935     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.03.043     Document Type: Article

References (46)

1. Uccelli A., Benvenuto F., Laroni A., Giunti D. Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol 2011, 24:59-64.
2. Gensel J.C., Donnelly D.J., Popovich P.G. Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Expert Opin Ther Targets 2011, 15:505-518.
3. Azari M.F., Mathias L., Ozturk E., Cram D.S., Boyd R.L., Petratos S. Mesenchymal stem cells for treatment of CNS injury. Curr Neuropharmacol 2010, 8:316-323.
4. Hernándeza J., Torres-Espína A., Navarro X. Adult stem cell transplants for spinal cord injury repair: current state in preclinical research. Curr Stem Cell Res Ther 2011, 6:273-287.
5. Willerth S.M. Neural tissue engineering using embryonic and induced pluripotent stem cells. Stem Cell Res Ther 2011, 2:17.
6. Ryu H.H., Byeon Y.E., Park S.S., Kang B.J., Seo M.S., Park S.B., et al. Immunohistomorphometric analysis of transplanted umbilical cord blood-derived mesenchymal stem cells and the resulting anti-inflammatory effects on nerve regeneration of injured canine spinal cord. Tissue Eng Reg Med 2011, 8:173-182.
7. Nandoe Tewarie R.D., Hurtado A., Levi A.D., Grotenhuis J.A., Oudega M. Bone marrow stromal cells for repair of the spinal cord: towards clinical application. Cell Transplant 2006, 15:563-577.
8. Parr A.M., Tator C.H., Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 2007, 40:609-619.
9. Ronsyn M.W., Daans J., Spaepen G., Chatterjee S., Vermeulen K., D'Haese P., et al. Plasmid-based genetic modification of human bone marrowderived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord. BMC Biotechnol 2007, 7:90.
10. Cizkova D., Rosocha J., Vanicky I., Jergova S., Cizek M. Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol Neurobiol 2006, 26:1167-1180.
11. Torrente Y., Polli E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant 2008, 17:1103-1113.
12. Webber D.J., Bradbury E.J., McMahon S.B., Minger S.L. Transplanted neural progenitor cells survive and differentiate but achieve limited functional recovery in the lesioned adult rat spinal cord. Regen Med 2007, 2:929-945.
13. Li Y., Zhang W.M., Wang T.H. Optimal location and time for neural stem cell transplantation into transected rat spinal cord. Cell Mol Neurobiol 2011, 31:407-414.
14. Samadikuchaksaraei A. An overview of tissue engineering approaches for management of spinal cord injuries. J Neuroeng Rehabil 2007, 4:15.
15. Potter W., Kalil R.E., Kao W.J. Biomimetic material systems for neural progenitor cell-based therapy. Front Biosci 2008, 13:806-821.
16. Sionkowska A. Current research on the blends of natural and synthetic polymers as new biomaterials: review. Prog Polym Sci 2011, 36:1254-1276.
17. Kim M.S., Kim J.H., Min B.H., Chun H.J., Han D.K., Lee H.B. Polymeric scaffolds for regenerative medicine. Polym Rev 2011, 51:1-30.
18. Tuinstra H.M., Aviles M.O., Shin S., Holland S.J., Zelivyanskaya M.L., Fast A.G., et al. Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury. Biomaterials 2012, 33:1618-1626.
19. De Laporte L., des Rieux A., Tuinstra H.M., Zelivyanskaya M.L., De Clerck N.M., Postnov A.A., et al. Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury. J Biomed Mater Res A 2011, 98:372-382.
20. Yang Y., De Laporte L., Zelivyanskaya M.L., Whittlesey K.J., Anderson A.J., Cummings B.J., et al. Multiple channel bridges for spinal cord injury: cellular characterization of host response. Tissue Eng Part A 2009, 15:3283-3295.
21. De Laporte L., Huang A., Ducommun M.M., Zelivyanska M.L., Aviles M.O., Adler A.F., et al. Patterned transgene expression in multiple-channel bridges after spinal cord injury. Acta Biomater 2010, 6:2889-2897.
22. Iseda T., Okuda T., Kane-Goldsmith N., Mathew M., Ahmed S., Chang Y.W., et al. Single, high-dose intraspinal injection of chondroitinase reduces glycosaminoglycans in injured spinal cord and promotes corticospinal axonal regrowth after hemisection but not contusion. J Neurotrauma 2008, 25:334-349.
23. Vinit S., Kastner A. Descending bulbospinal pathways and recovery of respiratory motor function following spinal cord injury. Respir Physiol Neurobiol 2009, 169:115-122.
24. Joo N.Y., Knowles J.C., Lee G.S., Kim J.W., Kim H.W., Son Y.J., et al. Effects of phosphate glass fiber-collagen scaffolds on functional recovery of completely transected rat spinal cords. Acta Biomater 2012, http://dx.doi.org/10.1016/j.actbio.2012.01.026.
25. Blight A.R., Young W. Central axons in injured cat spinal cord recover electrophysiological function following remyelination by Schwann cells. J Neurol Sci 1989, 91:15-34.
26. Alluin O., Karimi-Abdolrezaee S., Delivet-Mongrain H., Leblond H., Fehlings M.G., Rossignol S. Kinematic study of locomotor recovery after spinal cord clip compression injury in rats. J Neurotrauma 2011, 28:1963-1981.
27. Rossignol S., Barrière G., Alluin O., Frigon A. Re-expression of locomotor function after partial spinal cord injury. Physiol 2009, 24:127-139.
28. Gauthier P., Baussart B., Stamegna J.C., Tadié M., Vinit S. Diaphragm recovery by laryngeal innervation after bilateral phrenicotomy or complete C2 spinal section in rats. Neurobiol Dis 2006, 24:53-66.
29. Qi M.L., Wakabayashi Y., Enomoto M., Shinomiya K. Changes in neurocan expression in the distal spinal cord stump following complete cord transection: a comparison between infant and adult rats. Neurosci Res 2003, 45:181-188.
30. Ditunno J.F., Cohen M.E., Hauck W.W., Jackson A.B., Sipski M.L. Recovery of upper-extremity strength in complete and incomplete tetraplegia: a multicenter study. Arch Phys Med Rehabil 2000, 81:389-393.
31. Pal R., Gopinath C., Rao N.M., Banerjee P., Krishnamoorthy V., Venkataramana N.K., et al. Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury. Cytotherapy 2010, 12:792-806.
32. Lee K.H., Suh-Kim H., Choi J.S., Jeun S.S., Kim E.J., Kim S.S., et al. Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats. Acta Neurobiol Exp (Wars) 2007, 67:13-22.
33. Neuhuber B., Himes B.T., Shumsky J.S., Gallo G., Fischer I. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 2005, 1035:73-85.
34. Sheth R.N., Manzano G., Li X., Levi A.D. Transplantation of human bone marrow derived stromal cells into the contused spinal cord of nude rats. J Neurosurg Spine 2008, 8:153-162.
35. Wright K.T., Masri W.E., Osman A., Roberts S., Trivedi J., Ashton B.A., et al. The cell culture expansion of bone marrow stromal cells from humans with spinal cord injury: implications for future cell transplantation therapy. Spinal Cord 2008, 46:811-817.
36. Himes B.T., Neuhuber B., Coleman C., Kushner R., Swanger S.A., Kopen G.C., et al. Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil Neural Repair 2006, 20:278-296.
37. Blanc K.L., Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007, 262:509-525.
38. Togashi I., Suzuki J., Satake M., Nakamizo H., Tanaka M., Tsuji H., et al. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res 2010, 106:1613-1623.
39. Lin Y., Chern Y., Shen C.J., Wen H., Chang Y., Li H., et al. Human Mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in huntington's disease mouse models. PLoS ONE 2011, 6:e22924.
40. He L., Zhang Y., Zeng C., Ngiam M., Liao S., Quan D., et al. Manufacture of PLGA multiple-channel conduits with precise hierarchical pore architectures and in vitro/vivo evaluation for spinal cord injury. Tissue Eng Part C Methods 2009, 15:243-255.
41. Johnson P.J., Tatara A., McCreedy D.A., Shiu A., Sakiyama-Elbert S.E. Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter 2010, 6:5127-5137.
42. Irwin E.F., Gupta R., Dashti D.C., Healy K.E. Engineered polymer-media interfaces for the long-term self-renewal of human embryonic stem cells. Biomaterials 2011, 32:6912-6919.
43. Wang J.M., Zeng Y.S., Wu J.L., Li Y., Teng Y.D. Cograft of neural stem cells and Schwann cells overexpressing TrkC and neurotrophin-3 respectively after rat spinal cord transaction. Biomaterials 2011, 32:7454-7468.
44. Min S.H., Lee S.H., Shim H., Park J.S., Lee Y.I., Kim H.W., et al. Development of complete thoracic spinal cord transection model in rats for delayed transplantation of stem cells. Spine (Phila Pa 1976) 2011, 36:E155-E163.
45. de Haan P., Kalkman C.J. Spinal cord monitoring: somatosensory- and motor-evoked potentials. Anesthesiol Clin North America 2001, 19:923-945.
46. Lim P.A., Tow A.M. Recovery and regeneration after spinal cord injury: a review and summary of recent literature. Ann Acad Med Singapore 2007, 36:49-57.